Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
(A) Overall survival | ||||||
 T stage | ||||||
  T3–4 vs T1–2 | 7.417 | 4.985–11.035 | < 0.001 | 2.531 | 1.547–4.141 | < 0.001 |
 Lymph-node status | ||||||
  N1–2 vs N0 | 7.141 | 4.681–10.895 | < 0.001 | 3.969 | 2.431–6.482 | < 0.001 |
 Distant metastasis | ||||||
  M1 vs M0 | 13.621 | 7.747–23.946 | < 0.001 | 3.809 | 2.074–6.995 | < 0.001 |
 Fuhrman grade | ||||||
  G3–4 vs G1–2 | 4.594 | 3.067–6.883 | < 0.001 | 1.946 | 1.198–3.161 | 0.007 |
 CR-1 expression | ||||||
  High vs low | 7.031 | 4.068–12.152 | < 0.001 | 6.518 | 3.689–11.516 | < 0.001 |
(B) Recurrence-free survival | ||||||
 T stage | ||||||
  T3–4 vs T1–2 | 5.380 | 3.409–8.490 | < 0.001 | 2.051 | 1.167–3.606 | 0.013 |
 Lymph-node status | ||||||
  N1–2 vs N0 | 6.320 | 3.836–10.410 | < 0.001 | 4.818 | 2.581–8.995 | < 0.001 |
 Fuhrman grade | ||||||
  G3–4 vs G1–2 | 3.685 | 2.302–5.897 | < 0.001 | 1.783 | 1.045–3.043 | 0.034 |
 CR-1 expression | ||||||
  High vs low | 5.133 | 3.058–8.616 | < 0.001 | 5.638 | 3.274–9.711 | < 0.001 |